Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: The lumos-t safely reduces routine office device follow-up (TRUST) trial

Keyphrases

• Office Visits 100%
• Remote Monitoring 100%
• Device Follow-up 100%
• Lumo 100%
• Implantable Cardioverter-defibrillator 100%
• Physician Evaluation 50%
• Coronary Artery Disease 25%
• Left Ventricular Ejection Fraction 25%
• Median Time 25%
• Time Elapsed 25%
• Patient Condition 25%
• Primary Prevention 25%
• Rapid Detection 25%
• New York Heart Association Class 25%
• Implantable Cardiac Devices 25%
• Event Occurrence 25%
• Significant Events 25%
• Dual-chamber 25%
• Background Monitoring 25%
• Implantable Electronics 25%
• Device Evaluation 25%
• Electronic Cardiac Devices 25%
• Remote Home Monitoring 25%
• Conventional Monitoring 25%

Nursing and Health Professions

• Ambulatory Care 100%
• Implantable Cardioverter Defibrillator 100%
• Remote Sensing 100%
• Efficacy 100%
• Accident Prevention 100%
• Morbidity 50%
• Coronary Artery Disease 25%
• Primary Prevention 25%
• Heart Left Ventricle Ejection Fraction 25%
• Implant 25%
• New York Heart Association Class 25%
• Cardiac Equipment 25%
• Cardiac Implantable Electronic Device 25%
• Home Monitoring 25%

Medicine and Dentistry

• Morbidity 100%
• Remote Sensing 100%
• Implantable Cardioverter Defibrillator 100%
• Coronary Artery Disease 50%
• Heart Left Ventricle Ejection Fraction 50%
• Implant 50%
• Primary Prevention 50%
• New York Heart Association Class 50%
• Home Monitoring 50%
• Pacemaker 50%